The European Medicines Agency (“EMA”) has issued a new submission form in order to help marketing authorisation holders to submit the post-approval data that is generated to satisfy post-authorisation ...
The European Medicines Agency (EMA) has accepted Valneva’s marketing authorisation application (MAA) for its COVID-19 vaccine candidate, VLA2001. The COVID-19 vaccine candidate can now move from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback